Timothy Hlavinka
Urology · San Antonio, TXNPI 1982684098
Payments from drug & device makers
Across 119 payments — averaging $24.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$401
- Myovant Sciences Inc.$276
- Procept Biorobotics Corporation$274
- Astellas Pharma US Inc$221
- Johnson & Johnson$205
- Pfizer$188
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,852100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $401 |
| Myovant Sciences Inc. | 13 | $276 |
| Procept Biorobotics Corporation | 3 | $274 |
| Astellas Pharma US Inc | 12 | $221 |
| Johnson & Johnson | 11 | $205 |
| Pfizer | 12 | $188 |
| Antares Pharma, Inc. | 8 | $136 |
| Profound Medical Corp. | 1 | $135 |
| Bayer | 5 | $94 |
| Urovant Sciences Inc | 4 | $84 |
| Dendreon Pharmaceuticals LLC | 3 | $80 |
| Urogen Pharma, Inc. | 3 | $58 |
| Endo Pharmaceuticals Inc. | 3 | $53 |
| Myriad Genetic Laboratories, Inc. | 1 | $52 |
| Travere Therapeutics, Inc. | 3 | $51 |
| Amgen | 3 | $46 |
| Acerus Pharmaceuticals Corporation | 3 | $46 |
| Tolmar Pharmaceuticals, Inc. | 2 | $42 |
| Merck | 2 | $41 |
| AbbVie | 2 | $37 |
| Bluewind Medical | 1 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Zyla Life Sciences, Inc. | 2 | $28 |
| Tolmar, Inc. | 1 | $27 |
| Blue Earth Diagnostics | 1 | $25 |
| AstraZeneca | 1 | $24 |
| 180 Medical, Inc. | 1 | $23 |
| RGH Enterprises LLC | 1 | $21 |
| Neotract Inc. | 1 | $19 |
| Medtronic | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $17 |
| Ambu Inc. | 1 | $16 |
| Cook Medical LLC | 1 | $16 |
| Baudax Bio Inc. | 1 | $15 |
| Levita Magnetics International Corp | 1 | $15 |
| Novo Nordisk | 1 | $12 |
| Urogpo LLC | 2 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,863 in reported general payments places this provider in the 40th percentile of 878 urology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Silodosin | 27 | $2,524 |
| Dutasteride | 24 | $1,040 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $277 |
| Tamsulosin Hcl | 18 | $187 |
| Fluconazole | 14 | $150 |
| Levofloxacin | 17 | $150 |
| Anastrozole | 13 | $91 |
Paid to pharmacies, not to this prescriber.
Other urology in San Antonio
- Jose de la CerdaSan Antonio$9M
- Daniel SaltzsteinSan Antonio$5.8M
- Daniel ZainfeldSan Antonio$4.7M
- Kenneth StallmanSan Antonio$1.3M
- Naveen KellaSan Antonio$1M
- Robert SvatekSan Antonio$818K
- Leroy JonesSan Antonio$556K
- Christopher CantrillSan Antonio$348K
- Maurilio Garcia-GilSan Antonio$296K
- Zvi SchiffmanHouston$17.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.